"mutation"	"gene"	"function_category"	"comb_mutation"	"heterozygosity"	"citation"	"source"	"function_description"
"T220A"	"VP37"	"drug resistence"	""	""	" Garrigues et al. (2023) "	" https://doi.org/10.1128/aac.00568-23"	" May represent novel Tecovirimat-resistence mutation as likely at the interaction interface for the drug and observed in two site samples (0.44 and 0.49 frequency, culture  contaminated and culture negative respectively) from an HIV-positive patient treated with Tecovirimat."
"T220I"	"VP37"	"drug resistence"	""	""	" Garrigues et al. (2023) "	" https://doi.org/10.1128/aac.00568-23"	" May represent novel Tecovirimat-resistence mutation as likely at the interaction interface for the drug and observed in two site samples (0.44 and 0.49 frequency, culture  contaminated and culture negative respectively) from an HIV-positive patient treated with Tecovirimat."
"T245I"	"VP37"	"drug resistence"	""	""	" Garrigues et al. (2023) "	" https://doi.org/10.1128/aac.00568-23"	" May represent novel Tecovirimat-resistence mutation as likely at the interaction interface for the drug and observed in a single site sample (0.12 frequency, culture positive with EC50 0.3820uM) from an HIV-positive patient treated with Tecovirimat, may be dragged along by D294V (known from literature) from same sample with 0.91 frequency."
"D294V"	"VP37"	"drug resistence"	""	""	" Garrigues et al. (2023) "	" https://doi.org/10.1128/aac.00568-23"	" May represent novel Tecovirimat-resistence mutation as likely at the interaction interface for the drug and observed in a single site sample (0.91 frequency, culture positive with EC50 0.3820uM) from an HIV-positive patient treated with Tecovirimat."
"A265D"	"VP37"	"drug resistence"	""	""	" Garrigues et al. (2023) "	" https://doi.org/10.1128/aac.00568-23"	" May represent novel Tecovirimat-resistence mutation as likely at the interaction interface for the drug and observed in a single site sample (0.5 frequency, culture contaminated) from an HIV-positive patient treated with Tecovirimat. Novel T220A also found at similar frequency (0.44) in the same sample, as well as A295E which is known from the literature (0.51 frequency)."
"T289A"	"VP37"	"drug resistence"	""	""	" Garrigues et al. (2023) "	" https://doi.org/10.1128/aac.00568-23"	" May represent novel Tecovirimat-resistence mutation as likely at the interaction interface for the drug and observed in a single site sample (0.41 frequency, culture data pending) from an HIV-positive patient treated with Tecovirimat."
